Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引：0

作者：

Nathan J. Lanning

Joshua P. Castle

Simar J. Singh

Andre N. Leon

Elizabeth A. Tovar

Amandeep Sanghera

Jeffrey P. MacKeigan

Fabian V. Filipp

Carrie R. Graveel

机构：

[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology

[2] Van Andel Research Institute,College of Human Medicine

[3] University of California Merced,undefined

[4] Michigan State University,undefined

来源：

Cancer & Metabolism | / 5卷

关键词：

Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Metabolic Profile of Triple-negative Breast Cancer in African-American Women Reveals Potential Biomarkers of Aggressive Disease
Kanaan, Yasmine M.
Sampey, Brante P.
Beyene, Desta
Esnakula, Ashwini K.
Naab, Tammey J.
Ricks-Santi, Luisel J.
Dasi, Sylvia
Day, Agnes
Blackman, Kwesi W.
Frederick, Wayne
Copeland, Robert L., Sr.
Gabrielson, Edward
Dewitty, Robert L., Jr.
CANCER GENOMICS & PROTEOMICS, 2014, 11 (06) : 279 - 294
[22] Triple negative breast cancer: The role of metabolic pathways
Dean, Sarah J. R.
Rhodes, Anthony
MALAYSIAN JOURNAL OF PATHOLOGY, 2014, 36 (03) : 155 - 162
[23] Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Margarite Matossian
Nan Chen
Rita Nanda
Current Breast Cancer Reports, 2023, 15 : 266 - 278
[24] Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Matossian, Margarite
Chen, Nan
Nanda, Rita
CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 266 - 278
[25] Triple-negative breast cancer
Chacon, Reinaldo D.
Costanzo, Maria V.
BREAST CANCER RESEARCH, 2010, 12
[26] Triple-negative breast cancer
Stockmans, Gert
Deraedt, Karen
Wildiers, Hans
Moerman, Philippe
Paridaens, Robert
CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
[27] Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
Mizrahi, Avital Granit
Gugenheim, Ahinoam
Hamad, Haneen
Hamed, Roa'a
Tetro, Nino
Maimon, Ofra
Khutsurauli, Salome
Nechushtan, Hovav
Nisman, Benjamin
Duran, Deborah
Samman, Widad
Birimberg-Schwartz, Liron
Grunewald, Myriam
Eyal, Sara
Peretz, Tamar
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
[28] Demethoxycurcumin Inhibits Energy Metabolic and Oncogenic Signaling Pathways through AMPK Activation in Triple-Negative Breast Cancer Cells
Shieh, Jiunn-Min
Chen, Yung-Chan
Lin, Ying-Chao
Lin, Jia-Ni
Chen, Wei-Chih
Chen, Yang-Yuan
Ho, Chi-Tang
Way, Tzong-Der
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2013, 61 (26) : 6366 - 6375
[29] Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer
Duchnowska, Renata
Jarzab, Michal
Zebracka-Gala, Jadwiga
Matkowski, Rafal
Kowalczyk, Anna
Radecka, Barbara
Kowalska, Malgorzata
Pfeifer, Aleksandra
Foszczynska-Kloda, Malgorzata
Musolino, Antonino
Czartoryska-Arlukowicz, Bogumila
Litwiniuk, Maria
Surus-Hyla, Anna
Szablowska-Siwik, Sylwia
Karczmarek-Borowska, Bozenna
Debska-Szmich, Sylwia
Glodek-Sutek, Beata
Sosinska-Mielcarek, Katarzyna
Chmielowska, Ewa
Kalinka-Warzocha, Ewa
Olszewski, Wojciech P.
Patera, Janusz
Zawrocki, Anton
Pliszka, Agnieszka
Tyszkiewicz, Tomasz
Rusinek, Dagmara
Oczko-Wojciechowska, Malgorzata
Jassem, Jacek
Biernat, Wojciech
CLINICAL BREAST CANCER, 2017, 17 (02) : E65 - E75
[30] Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
Tatiana J. Carneiro
Ana L. M. Batista Carvalho
Martin Vojtek
Inês F. Carmo
Maria Paula M. Marques
Carmen Diniz
Ana M. Gil
Cancer Cell International, 23

← 1 2 3 4 5 →